Alebund Pharmaceuticals (Jiangsu) Limited Class H · HKEX:9637
Alebund Pharmaceuticals (Jiangsu) Limited Class H shareholders
Alebund Pharmaceuticals (Jiangsu) Limited Class H on 6ix: holders from US fund reports. Largest: Lazard Emerging Markets Opportunities ETF, Vanguard International Explorer Fund and The Hartford Healthcare Fund. Each with its filing.
| Holder | Shares | % of Alebund Pharmaceuticals (Jiangsu) Limited Class H | Change | As of |
|---|---|---|---|---|
| Lazard Emerging Markets Opportunities ETF | 313K | new | Jun 30, 2026 | |
| Vanguard International Explorer Fund | 111K | new | Jul 31, 2026 | |
| The Hartford Healthcare Fund | 85,600 | new | Jul 31, 2026 | |
| Vanguard Emerging Markets Select Stock Fund | 33,600 | new | Jul 31, 2026 | |
| Nationwide International Small Cap Fund | 32,500 | new | Jul 31, 2026 | |
| NYLIM WMC International Research Equity Fund | 30,000 | new | Jul 31, 2026 | |
| Hartford Healthcare Hls Fund | 12,300 | new | Jun 30, 2026 | |
| Victory Science & Technology Fund | 1,100 | new | Jul 31, 2026 |
Alebund Pharmaceuticals (Jiangsu) Limited Class H insider trades